Our blogs and videos choice: hpv dna test

バイオとメディカルの特許翻訳の長文例(対訳中心:バイオ、医学、医薬 ...

対照的に、低リスクのHPV、例えばHPV-6及びHPV-11は、滅多に癌を発症させない。低リスクのHPV及び高リスクのHPVの存在が、ポリメラーゼ連鎖反応(「PCR」)又はHybrid Capture(登録商標) II HPV Test (「HC II HPV Test」;Digene Corp., ..... シグナル増幅法 の当該技術分野において既知の例は、分枝DNA(bDNA)シグナル増幅(Bayer Healthcare LLC, Tarrytown, N.Y.)、Hybrid Capture(「HC」;Digene Corp., Gaithersburg, MD.)、及びTyramideシグナル増幅(「TSA」Perkin Elmer, Inc., Wellesley, MA)。 [more...]

Date: 2010-09-29 12:17:28

Blog posts (30) | Videos (2)
 


Collect HPV pay with the right screening versus reflex diagnoses ...

A core ASCCP recommendation is to screen for high-risk HPV DNA in patients over the age of twenty years with a Pap cytologic result of 795.01 (Papanicolaou smear of cervix with atypical squamous cells of undetermined significance ). The guidelines also address the role of HPV with other Pap outcomes in special populations like recommending reflex HPV testing for postmenopausal women with cytologic findings of 795.03 (Papanicolaou smear of cervix with low grade squamous intraepithelial lesion ). Important: If your payers have adopted any or all of these guidelines, you will need [more...]

Date: 2010-10-11 05:08:32


Healthcare Sales & Marketing Network: James Godsey, Ph.D., to Join ...

Mr. Jones added that "Dr. Lorincz has led Digene's research since the company's founding. He was responsible for the development of the company's lead product - the Hybrid Capture® 2 HPV DNA Test. By expanding our scientific leadership team, Dr. Lorincz will have more time to foster our relationships with global scientific thought leaders and to explore possible new 'frontiers' for the company's growth." In addition to his work at Veridex and GenProbe, Dr. Godsey was President/COO of ThermoGenesis Corporation and he held a number of increasingly responsible positions with DADE Microscan [more...]

Date: 2006-10-27 21:26:00


The HPV Test - Web Resource

The site provides information about testing for the sexually transmitted human papillomavirus. The website was created by the Digene Corporation, the maker of the HC2 High-Risk HPV DNA Test, which is used to screen for 13 high-risk types of HPV which have been associated with the development of cervical cancer. The test is primarily for women over 30, who are considered to be at greater risk for developing cervical cancer. I would generally warn you to be cautious when using websites created by or for drug/biotechnology companies because they have a product to sell, a good general guideline [more...]

Date: 2006-09-14 02:43:00


12 Tests That Can Save Your Life

HPV DNA Testing. Tests for the human papilloma virus in sexually active females. This virus which comes in 100 types can cause changes in the cells of the cervix which may lead to cervical cancer. Again, it is worthy to note that early [more...]

Date: 2010-09-30 19:06:51


HPV DNA testing over 50 percent more sensitive than cytology testing

( Queen Mary, University of London ) HPV DNA testing for pre-cancers and cervical cancers is over 50 per cent more sensitive than cytology testing for the same conditions a community-based study in Mexico has revealed. [more...]

Date: 2010-07-08 15:59:25


Can you get HPV from your partner after it has already turned into ...

Even with negative DNA HPV testing the virus can be transmitted. The virus may not trigger an HPV test when the cancer is advanced but the virus is still in the shedding DNA. HPV DNA is found in virtually all (99.7%) cervical [more...]

Date: 2010-10-07 22:25:58


Roche and German Cancer Research Center (DKFZ) Enter Research ...

Nucleic acid (DNA) testing is a sensitive and non-invasive method for determining the presence of a cervical HPV infection.About DKFZThe German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is the largest biomedical research institute in Germany and is a member of the Helmholtz Association of National Research Centers. More than 2,200 staff members, including 1000 scientists, are investigating the mechanisms of cancer and are working to identify cancer risk factors. They provide the foundations for developing novel approaches in the prevention, diagnosis, and treatment of [more...]

Date: 2010-10-11 04:00:00


Human Papillomavirus DNA versus Papanicolaou Screening Tests for ...

Exclusion of young women and pregnant women normally screened for cervical cancer introduces a bias against Pap testing and for HPV DNA testing, negating the authors' sensitivity and specificity comparisons for general screening. [more...]

Date: 2008-02-06 21:55:23


Is the PAP test for cervical cancer screening being overused ...

However, the addition of the HPV DNA test has resulted in stronger recommendations by ACS and ACOG to extend screening intervals to three years without prior normal Pap test results, the researchers said. HPV testing has greater [more...]

Date: 2010-07-15 15:00:32


Dr. Renate Bodden, N.D. Announces Wingspan Wellness Retreats on ...

Maureen will be celebrating the grand opening of her new store by offering free delivery to the customer's door within a 20 mile radius. The Houston affiliate will continue to offer services at the original location bringing the total furniture .... Cancer Diagnostic Testing World Markets. Cancer Therapeutics Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Genetics Bundle: Bioinformatics Markets. DNA [more...]

Date: 2010-10-13 00:00:03


Abnormal Pap Test After HPV Vaccination? SaneVax Offers HPV DNA ...

PRLog To date, there have been 283 VAERS reports of abnormal Pap tests following HPV vaccination. Gardasil and Cervarix claim to offer protection against the most common HPV viruses associated with cervical cancer. [more...]

Date: 2010-09-22 01:43:13


Small Cell Cervical Cancer Survival Rates | Health For Everyone

Starting at age 30, women with three normal Pap test results in a row can switch to testing every two or three years. Talk with your doctor about how often you should have the test performed. All women should take the newer HPV DNA test [more...]

Date: 2010-10-13 11:18:24


Talks About Pregnancy Test

HPV testing – sometimes the cells can be checked to see if there is HPV DNA present. Often this can be done with the cells from the original Pap test, so the woman does not need to return to the office. Colposcopy – This test is done in [more...]

Date: 2010-10-07 04:47:16


Healthcare Sales & Marketing Network: Daryl J. Faulkner Appointed ...

The company's hc2 High-Risk HPV DNA Test® is the only test for human papillomavirus approved by the U.S. Food and Drug Administration (FDA), for both follow-up evaluation in women with inconclusive Pap results and for primary adjunctive screening with the Pap test in women age 30 and older. For primary adjunctive screening, it is marketed as both The Digene HPV Test and the DNAwithPap® Test. These brand names do not refer to the Digene product that tests for several types of the virus commonly referred to as "low-risk HPV," which are not associated with cervical cancer. For more [more...]

Date: 2006-11-14 20:43:00


Would this be Medicaid fraud?? Lab tests? | Fraud Prevention

low-risk HPV types (using the kit's Low-Risk HPV Probe) should not be used as an adjunct for screening, because low-risk types are not associated with risk of cervical cancer. Only the hc2 High-Risk HPV DNA Test [more...]

Date: 2010-09-22 21:06:28


Diagnosed With Genital Warts: Could This Have Been Misdiagnosed ...

The hc2 High-Risk HPV DNA Test™ (DNAwithPap™)* using Hybrid Capture2 (hc2) technology is an In Vitro nucleic acid hybridization assay with signal amplification using microplate chemiluminescence for the qualitative detection of thirteen high-risk types of human papillomavirus (HPV) DNA in cervical specimens. The HPV types detected by the assay are the high-risk HPV types 16/18/31/33/35/39/45/51/52/56/58/59/68… The hc2 High-Risk HPV DNA Test cannot determine the specific HPV type present. http://www.digene.com Genital warts can cause abnormal cell changes but most of these [more...]

Date: 2009-11-28 05:29:18


Dagens Medisin: Ny generasjon HPV-tester på vent

DNA-testene Sørbye sammenligner mRNA-testen med (Hybrid Capture 2 og Amplicore), har en positivitetsrate på henholdsvis 17 og 15 prosent. Til sammenligning har mRNA-testen (ProTect HPV-Proofer) en positivitetsrate på fem prosent. ... Poenget er at jo flere HPV-typer som legges til en test, desto mer sensitiv er testen. Samtidig vil det gjøre en positiv test desto mindre nyttig for klinikere og pasient, på grunn av lav spesifisitet og lav positiv prediktiv verdi for [more...]

Date: 2010-09-18 07:00:00


'Accurate Testing for Different Types Of Cancers' by youtestyou1 ...

Accurate Testing for Different Types Of Cancers Sort: New to old Old to new Subscribe to this journal Add to favorites Print 13 Oct It is your doctor’s responsibility to order the necessary tests to accurately and quickly diagnose your cancer if cancer is a possibility. The earlier your cancer is diagnosed, the more quickly you can begin treatment and increase your chance of survival. Here are some tests that should be run if you suspect cancer: Skin cancer: If your doctor thinks you have melanoma, he or she should take a biopsy from the area around the melanoma and send it to a pathology [more...]

Date: 2010-10-13 09:32:32


How is HPV Infection Diagnosed | Help for Genital Warts

Pap tests are the main way doctors find cervical cancer or precancerous changes in the cervix. To find out for sure if the changes are related to HPV, a doctor may decide to perform a DNA test to detect the virus in women who have an abnormal Pap smear. This tells you and your doctor whether the HPV virus you have can cause cancer. Only certain strains of HPV cause cancer. Indeed, HPV 16 and 18 account for 70% of all cervical cancers. This DNA test is often done on women who have mild Pap test abnormalities. It may also be done as part of a routine Pap test to women over age 30. In the HPV [more...]

Date: 2010-10-13 17:50:56


HPV DNA Test Better than the Pap Smear at Preventing Cervical ...

A DNA test for the human papillomavirus (HPV), the leading risk factor for cervical cancer, is better than the Pap smear and other screening methods at preventing cervical cancer according to a new study. The multi-year study of 131,746 women in India, published in last week's New England Journal of Medicine, showed that a single round of HPV DNA testing was more effective than other screening methods at preventing cervical cancer and related deaths.  Health experts believe that the widespread introduction of the DNA test for HPV could result in the elimination or reduction of use of the Pap [more...]

Date: 2009-04-08 20:30:08


Q&A: What types of HPV does the HPV test check you for? | HPV Network

Another Digene kit, the hc2 HPV DNA Test (Catalog Number: 5198-1220), which detects both high-risk (using the kit’s High-Risk HPV Probe) and some low-risk HPV types (using the kit’s Low-Risk HPV Probe) should not be used http://www.thehpvtest.com/About-the-digene-HPV-Test/HPV-Test-vs-the-Pap-FAQs/~/media/Files/QIAGENCMS/Corporate/Web/TheHPVTest/FAQ/PatientPI.ashx http://www.roche.com/med-cor-2004-04-19a Over 40 HPV types infect the anogenital tract, 15 of them have been classified as high-risk for development of cervical cancer, 3 have been classified as probable high-risk, 12 have [more...]

Date: 2010-09-11 15:27:18


HPV DNA Test for Cervical Cancer

According to Lab Tests Online, the HPV DNA test still requires a sample of cells from the cervix. It is NOT a blood test. I emphasize this point because most of the news I’ve seen either got it wrong or didn’t clarify the testing procedure. For most people, DNA tests still mean a blood test even though DNA can be extracted from other samples, such as the ubiquitous cheek swab. Currently, the HPV DNA test is used in combination with the traditional pap smear. However, recent studies have shown that HPV testing may be used alone and make it possible for women to prolong the time between [more...]

Date: 2007-10-22 11:30:43


Practical Diabetology Highlights Advanced Lipid Testing For Type 2 ...

Testing In Type 2 Diabetes TORONTO – A newly published study is raising questions about... HPV DNA Testing Over 50 Percent More Sensitive Than Cytology Testing ( Queen Mary, University of London ) HPV DNA testing... Firm To Fore In Diabetes Testing DUNDEE-BASED diagnostics firm Axis-Shield has teamed up with an American... MP Supports Type 2 Diabetes Testing WIRRAL South MP Ben Chapman attended an event in Parliament... Genetic Testing No Real Help In Predicting Type 2 Diabetes (PhysOrg.com) — New UCL research shows that genetic testing [more...]

Date: 2010-09-18 11:23:35


The best way to Detect and Stop Cervical Cancer

Screening tests embrace both standard Pap smear or liquid cytology, with or without HPV (human papilloma virus) DNA test. The current recommendations from the American Faculty of Obstetricians and Gynecologists for regular-risk ladies are as follows: 1) Pap smear to begin at age 21 2) 30 years of age: every three years 4) Cease screening at age 65-70, after three regular tests during the last 10 years. Screening is more frequent for prime risk women. Excessive risk circumstances embrace previous cervical cancer, publicity to DES (diethylstilbestrol) as a fetus, and immunocompromised [more...]

Date: 2010-10-09 16:52:28


Merck and QIAGEN NV partner to increase access to HPV vaccine and ...

The collaboration “will integrate two breakthrough and complementary advances in healthcare” – Merck’s cervical cancer vaccine, GARDASIL and QIAGEN’s digene HC2 HPV DNA Test (called the digene HPV Test) and a new HPV DNA test that is currently in development for use specifically in the developing world. Merck said it intends to provide, for free, up to five (5) million doses of GARDASIL and QIAGEN intends to add to its existing one million test donation program by providing HPV DNA tests to screen an additional 500,000 women. Merck and QIAGEN said they plan to seek other public and [more...]

Date: 2009-10-05 00:38:51


Does he hold genital wart? | Help for Genital Warts

High risk strains of HPV usually show up on pap tests as abnormal cervical cell. There is another HPV DNA test they can do at the same time as a pap that might detect it beforehand any abnormal cells appear. I am not sure… Does HPV (human pepalona virus) affect a pregnancy/baby approaching other diseases such as chlamydia? No. It can be passed on to your child but doctors quality that their immune systems can fight it before it can ever become a problem. I found out I have hpv back in July and told my doctor… Does HPV affect H1N1? I have HPV, strains that cause cancer and wart. How will [more...]

Date: 2010-10-13 12:50:48


Surgery words starting with H

HX-5/6-1 endoscopic clipping device Hyalgan® (sodium hyaluronate) Hybrid Capture® CMV DNA test Hybrid Capture® HPV DNA test Hybritech free PSA test Hybritech® PSA/free PSA blood tests Hycamtin™ (topotecan hydrochloride) Hycore-R™ controlled release morphine (Moraxen™) hyCURE™ Hydrasorb HydroBlade™ keratome HydroBrush™ keratome hydrofluoroalkane (HFA) HydroGel™ coated slides Hydrolatum™ (hydrated petrolatum) Hydro ThermAblator® (HTA®) system hydroxyurea hydroxyurea tablets, 1000 mg Hylagel-Nuro™ Hylagel® Uro Hylashield® (Canada); i.com Comfort [more...]

Date: 2010-08-17 21:31:00


Lobbying efforts by the American Society for Clinical Pathology ...

tion of Westcliff Medical Labs (Santa Ana, CA). LabCorp acquired Westcliff out of bankruptcy for $57.5 million on June 16 (see LE, June 2010, pp. 1-2). On. June 24, the FTC notified LabCorp that it intends to review the acquisition. Lab- ... DCL Labs, founded in 1984, operates a main lab in Indianapolis with a smaller lab in St. Louis. It specializes in women's health, including ThinPrep Pap testing, DNA-based HPV testing and. Chlamydia and gonorrhea testing. [more...]

Date: 2010-07-19 19:19:51


HTB – HPV-based screen-and-treat is effective for cervical cancer ...

For VIA this was nearly three times higher in the HIV-positive than HIV-negative women. The investigators explained that this was due to 62.2% of HIV-positive women with positive VIA test also having had HPV DNA detected vs. 26.6% of HIV-negative women. When they compared cryotherapy failure rates between HIV-positive and HIV-negative women, in the HPV-and-treat group, there was a slightly lower rate of CIN2+ after cryotherapy in HIV-positive (2.8%) vs HIV-negative (7.1%) women, p=0.05. In the VIA-and-treat group failure rates were similar in HIV-positive (4.8%) and negative (2.8%) women, [more...]

Date: 2010-09-29 05:37:21



30 Results